Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

NCT05475665 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Irbesartan/Amlodipine
DRUG: Irbesartan

Sponsor

Handok Inc.